Skip to main content
OpenTrials

Clinical trial condition

Stage IV Breast Cancer AJCC v6 and v7

Explore clinical trials studying Stage IV Breast Cancer AJCC v6 and v7. Study availability and eligibility vary by location and protocol.

39 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Stage IV Breast Cancer AJCC v6 and v7 trial results

Completed

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

NCT00390455

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive, +11 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Arroyo Grande Community Arroyo Grande, California, United States
  • PCR Oncology Arroyo Grande, California, United States
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
View all 368 locations
View Trial Details
Completed

Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

NCT00699491

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +7 more
Locations
  • Palo Alto Medical Foundation Health Care Palo Alto, California, United States
  • Valley Medical Oncology Consultants Pleasanton, California, United States
  • The Medical Center of Aurora Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
View all 192 locations
View Trial Details
Completed

Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer

NCT01145430

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +30 more
Locations
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
  • Mount Sinai Hospital New York, United States
  • Columbia University/Herbert Irving Cancer Center New York, United States
  • Weill Medical College of Cornell University New York, United States
View Trial Details
Active, Not Recruiting

Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer

NCT01463072

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Carcinoma, +11 more
Locations
  • City of Hope medical Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer

NCT01351909

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Unresectable Breast Carcinoma, +9 more
Locations
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • Montefiore Medical Center-Weiler Hospital The Bronx, New York, United States
View Trial Details
Active, Not Recruiting

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

NCT02311933

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +9 more
Locations
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 560 locations
View Trial Details

Related conditions